Original language | English |
---|---|
Pages (from-to) | 368-369 |
Number of pages | 2 |
Journal | Annals of Oncology |
Volume | 30 |
Publication status | Published - Oct-2019 |
Event | 44th Congress of the European-Society-for-Medical-Oncology (ESMO) - Barcelona, Spain Duration: 27-Sept-2019 → 1-Oct-2019 |
Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma
Y. Loriot, C. N. Sternberg, D. Castellano Gauna, H. Dumez, R. Huddart, K. M. Vianna, T. Alonso Gordoa, I. A. Skoneczna, A. Fay, C. S. P. Sacco, F. Nole, F. Massari, B. Brasiuniene, P. Maroto, S. F. Oosting, S. Fear, F. Di Nucci, S. De Ducla, E. Choy
Research output: Contribution to journal › Meeting Abstract › Academic